Phenylpropanoids

Other Names

4-HydroxyphenylpropanoidsC6-C3 compoundsCaffeoyl phenylethanoid glycosidesCinnamic acid derivativesCPGsHydroxycinnamic acid derivativesMonolignolsPhenolic compoundsPhenylethanoid glycosidesPhenylpropanoid compoundsPhenylpropanoid glycosidesPhenylpropanoid secondary metabolitesPhenylpropenesPhGsPlant aromatic secondary metabolitesPlant phenolicsPlant polyphenolsPPGsPPPsSecondary metabolites (phenylpropanoid-derived)Shikimate pathway metabolitesShikimate/phenylpropanoid pathway products

Synopsis

Phenylpropanoids: A Comprehensive Reference

1. Identity, Chemical Nature, and Classification

The phenylpropanoids are a diverse family of organic compounds biosynthesized by plants from the amino acids phenylalanine and tyrosine via the shikimic acid pathway. Their name is derived from the six-carbon, aromatic phenyl group and the three-carbon propene tail of coumaric acid, which is the central intermediate in phenylpropanoid biosynthesis. This shared core structure, often denoted as the C6–C3 scaffold, underpins an enormous chemical diversity. Phenylpropanoid compounds, which bear a C6–C3 phenolic scaffold, have received particular attention not only because of their function in plants but also because of their wide spectrum of biological activities.

Phenylpropanoids are a large class of plant secondary metabolites derived from the aromatic amino acid phenylalanine in most plants, or tyrosine in some monocots. The class mainly includes flavonoids, mono-lignols, coumarins, stilbenes, lignans, and hydroxycinnamic acids, among others. From 4-coumaroyl-CoA emanates the biosynthesis of myriad natural products including lignols (precursors to lignin and lignocellulose), flavonoids, isoflavonoids, coumarins, aurones, stilbenes, catechin, and phenylpropanoids.

The primary structural subclasses encountered in dietary supplement and natural health contexts include:

Hydroxycinnamic acids — including caffeic acid, ferulic acid, p-coumaric acid, sinapic acid, and chlorogenic acid.
Phenylpropanoid glycosides (PPGs) — including acteoside (verbascoside), echinacoside, forsythiaside A, and plantamajoside.
Volatile phenylpropanoids — including cinnamaldehyde, eugenol, anethole, estragole, safrole, myristicin, and elemicin.
Rosmarinic acid — a polyphenolic ester of caffeic acid and a hydroxyphenyllactic acid derivative.
Coumarins — including scopoletin, auraptene, and umbelliferone, biosynthesized by cyclization of hydroxycinnamic acid precursors.
Lignans — dimeric phenylpropanoids formed by oxidative coupling of two C6–C3 units.
Flavonoids and isoflavonoids — though frequently classified separately, these are biosynthetically derived from the general phenylpropanoid pathway via chalcone synthase acting on 4-coumaroyl-CoA.

Phenylpropanoids and their derivatives are plant secondary metabolites widely present in fruits, vegetables, cereal grains, beverages, spices, and herbs. Phenylpropanoids are present in commercially available dietary supplements and skin care products.

2. Biosynthesis and Natural Sources

2.1 The General Phenylpropanoid Pathway

A main pathway for the formation of phenolic compounds starts with the aromatic amino acids L-phenylalanine and, to a lesser extent, L-tyrosine. In the general phenylpropanoid pathway, these are transformed to coenzyme A-activated 4-coumaric acid by phenylalanine ammonia-lyase (PAL), cinnamic acid 4-hydroxylase (C4H), and 4-coumarate CoA-ligase (4CL). 4-Coumaroyl-CoA then gives rise to a large number of different natural products, including flavonoids, lignans, coumarins, tannins, hydroxycinnamic acid esters and amides, as well as lignin monomers.

These compounds are biosynthesized from shikimic acid, which forms the basic units of cinnamic and p-coumaric acids. These units, through enzymatic reductions, produce propenylbenzenes and/or allylbenzenes, and through oxidations with side-chain degradation, generate aromatic aldehydes.

The general phenylpropanoid pathway is not only restricted to common lignin or flavonoid biosynthesis, but feeds into a variety of other aromatic metabolites like coumarins, phenolic volatiles, and hydrolyzable tannins.

2.2 Dietary and Botanical Sources

Phenylpropanoids (PPs) belong to the largest group of secondary metabolites produced by plants, mainly in response to biotic or abiotic stresses such as infections, wounding, UV irradiation, exposure to ozone, pollutants, and other hostile environmental conditions. They serve to attract pollinators, support secondary cell-wall growth, provide protection against various plant diseases, and interact with beneficial soil microbes.

Key botanical sources by compound subclass include:

Ferulic acid: Ferulic acid is the most abundant phenolic compound found in vegetables and cereal grains. It is widely used in the food (namely whole grains, fruits, vegetables, and coffee), pharmaceutical, and cosmetics industries.
Rosmarinic acid: In nature, rosmarinic acid is produced by plants in the mint family (Lamiaceae) and in some members of the borage family (Boraginaceae). Culinary herbs such as rosemary, lemon balm, sage, thyme, basil, oregano, marjoram, perilla, and spearmint are among the richest dietary sources.
p-Coumaric acid: p-Coumaric acid (p-CouA), a phenolic compound, is a cinnamic acid derivative found in several fruits, vegetables, and herbs.
Common phenolic acids (caffeic, carnosic, ferulic, gallic, p-coumaric, rosmarinic, vanillic): A few of the most common naturally occurring phenolic acids have been identified as ingredients of edible botanicals (thyme, oregano, rosemary, sage, mint, etc.).
Volatile phenylpropanoids: Estragole is a volatile phenylpropanoid belonging to a group of alkenylbenzenes such as eugenol, isoeugenol, methyleugenol, safrole, isosafrole, anethole, elemicin, and myristicin. These occur in cinnamon, clove, anise, fennel, basil, and related spices.
Verbascoside (acteoside): In addition to mullein, verbascoside exists in a variety of medicinal plants, such as Aloysia citriodora, Rehmannia glutinosa, Cistanche deserticola, Osmanthus sp., Pedicularis resupinata, Achyranthes aspera, and Syringa vulgaris.
Cereals and legumes: A paradigm shift was noted in barley, maize, rice, sorghum, soybean, and wheat, wherein cultivars rich in phenylpropanoids are grown in Europe and North and Central America.

These numerous phenolic compounds are major biologically active components of human diet, spices, aromas, wines, beer, essential oils, propolis, and traditional medicine.

3. Traditional and Historical Use

The dietary and medicinal use of phenylpropanoid-rich plants spans virtually all ancient and indigenous medical traditions. Because the term "phenylpropanoid" is a modern chemical classification, historical practitioners used the plants themselves — identified by their aromatic volatile oils, spicy resins, or bitter flavors that are now understood to arise from their phenylpropanoid content.

3.1 Chinese Traditional Medicine

Phenylpropanoid-rich plants occupy a central position in Traditional Chinese Medicine (TCM). Cistanche species (containing echinacoside, acteoside, and related PPGs) have been used for centuries as kidney-tonifying agents and for fatigue and sexual insufficiency. There is an increasing need for improving analytical methods for identification of active components and quality control of traditional Chinese medicine; in one study, an HPLC method was developed to simultaneously determine eight phenylethanoid glycosides in different species of the genus Cistanche, namely acteoside, 2′-acetylacteoside, cistanoside A, cistanoside C, cistanoside F, echinacoside, isoacteoside, and tubuloside A. Cinnamon bark (Cinnamomum cassia) — rich in cinnamaldehyde — has been employed in Chinese medicine for thousands of years to treat cold disorders, digestive ailments, and cardiovascular conditions.

3.2 Ayurvedic and South Asian Traditions

Eugenol-rich clove (Syzygium aromaticum) and cinnamon were central to Ayurvedic preparations used for digestive complaints, toothache, and as general tonics. Historically, basil is used medicinally for gastrointestinal disorders, respiratory ailments, wound care, and general therapeutic purposes within traditional healing systems. The Ayurvedic tradition of the Indian subcontinent represents the most codified and historically documented ethnomedicinal system engaging Ocimum species, whose essential oils contain eugenol, estragole, and other volatile phenylpropanoids.

3.3 Mediterranean and European Traditions

In ancient Egypt, basil was documented as both a culinary and medicinal plant. In north Africa, particularly Egypt, basil has been used for centuries for both culinary and medicinal purposes, with archaeological evidence indicating its cultural significance. Throughout the Mediterranean, aromatic herbs of the Lamiaceae family — including rosemary, sage, thyme, and oregano — were used in decoctions, infusions, and topical preparations for wounds, respiratory ailments, and digestive disturbances; these herbs are now known to concentrate rosmarinic acid, caffeic acid, and related hydroxycinnamic acids. In medieval European herbalism, fennel (Foeniculum vulgare), rich in the volatile phenylpropanoid anethole, was used for flatulence, infant colic, and to promote lactation. Anise, another anethole-dominant plant, was similarly employed across Greek, Roman, and later European folk medicine.

3.4 North American Indigenous Traditions

Echinacea species (Echinacea angustifolia, E. purpurea), which contain echinacoside (a phenylpropanoid glycoside) alongside alkamides and polysaccharides, were extensively used by Plains Native Americans to treat infections, snakebite, and toothache. The first published references about phenylethanoid glycosides concerned the isolation of echinacoside from Echinacea angustifolia (Asteraceae) in 1950 — a landmark that brought scientific attention to this compound class.

3.5 Preparations and Forms in Traditional Use

Traditional preparations involving phenylpropanoid-rich plants encompassed water-based decoctions and infusions (teas), alcoholic tinctures and extracts, expressed plant oils, topical poultices and ointments, steam inhalation of volatile oils, and incorporation into food and condiments. The preparation method significantly influenced which phenylpropanoids were extracted: water extracts favor glycosylated and polar phenylpropanoids (such as PPGs and hydroxycinnamic acid conjugates), while alcoholic extracts and steam distillation favor volatile aglycones such as eugenol, cinnamaldehyde, and anethole.

4. Key Constituents and Chemical Classes

4.1 Hydroxycinnamic Acids

Ferulic acid ((E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid): Ferulic acid is a derivative of caffeic acid found in most plants. This abundant phenolic compound exhibits significant antioxidant capacity and a broad spectrum of therapeutic effects, including anti-inflammatory, antimicrobial, anticancer, antidiabetic, cardiovascular, and neuroprotective activities. It is absorbed more quickly by the body and stays in the bloodstream for a longer period compared with other phenolic acids.

Caffeic acid (3,4-dihydroxycinnamic acid): A ubiquitous hydroxycinnamic acid found in coffee, many vegetables, and as an ester in chlorogenic acid. It is the phenylpropanoid moiety within rosmarinic acid and acteoside.

p-Coumaric acid (4-hydroxycinnamic acid): p-Coumaric acid is a phenolic acid that has low toxicity in mice (LD₅₀ = 2850 mg kg⁻¹ body weight), serves as a precursor of other phenolic compounds, and exists either in free or conjugated form in plants. Its biological activities include antioxidant, anti-cancer, antimicrobial, antivirus, anti-inflammatory, antiplatelet aggregation, anxiolytic, antipyretic, analgesic, and anti-arthritis activities.

Rosmarinic acid: Rosmarinic acid is a polyphenolic ester formed from two smaller phenolic compounds, caffeic acid and 3,4-dihydroxyphenyllactic acid. Rosmarinic acid (RA) is a bioactive phenolic compound commonly found in plants of Lamiaceae and Boraginaceae families; it is biosynthesized using the amino acids tyrosine and phenylalanine via enzyme-catalyzed reactions.

4.2 Phenylpropanoid Glycosides (PPGs)

Phenylpropanoid glycosides (PPGs) are natural compounds present in several medicinal plants that have high antioxidant power and diverse biological activities. Because of their low content in plants (less than 5% w/w), several chemical synthetic routes to produce PPGs have been developed.

Acteoside (verbascoside): Verbascoside (C₂₉H₃₆O₁₅, MW 624.6 g/mol) is a water-soluble disaccharide derivative related to trans-caffeic acid and hydroxytyrosol. It consists of four components: caffeic acid, glucose, rhamnose, and hydroxytyrosol. Investigation of biosynthetic pathways revealed that the hydroxytyrosol moiety is synthesized from tyrosine by the shikimate pathway, while the caffeoyl moiety is derived from phenylalanine by the cinnamate pathway. The first PPG, acteoside (also referred to as verbascoside), was isolated by Scarpati et al. in 1963 from medicinal plants in the family Basalaceae. Since then, hundreds of PPGs have been isolated and identified, highlighting the diversity and therapeutic promise of this compound class.

Echinacoside: A related phenylethanoid glycoside isolated from Echinacea angustifolia roots and several other plants in the Cistanche genus, well studied for antioxidant and neuroprotective properties.

4.3 Volatile Phenylpropanoids

Cinnamaldehyde (trans-3-phenylprop-2-enal): The principal aromatic component of cinnamon essential oil, responsible for the characteristic flavor and documented biological activities. Cinnamaldehyde suppressed NF-κB activation by inhibiting the ERK and p38 MAPK pathways, suggesting that the antioxidative effect and the restoration of redox balance were related to its anti-inflammatory activity.

Eugenol (4-allyl-2-methoxyphenol): The dominant component of clove essential oil, also present in cinnamon leaf, basil, and bay leaf. It is widely used as a dental analgesic.

Anethole (1-methoxy-4-propenylbenzene): The characteristic compound of anise (Pimpinella anisum), star anise (Illicium verum), and fennel.

Estragole (methyl chavicol): A structural isomer of anethole found in basil, tarragon, fennel, and anise. It is a volatile phenylpropanoid belonging to the alkenylbenzene group.

4.4 Coumarins

The general phenylpropanoid pathway feeds into coumarins through hydroxylation and lactonization of cinnamic acid derivatives. Representative members include scopoletin, umbelliferone, and auraptene (7-geranyloxycoumarin), all of which are being investigated for biological activity. Both auraptene and 7-isopentenyloxycoumarin have been demonstrated to exert neuroprotective effects, also in terms of amelioration of symptoms and clinical significance associated with the development and progress of Parkinson's disease.

5. Mechanisms of Action

5.1 Antioxidant and Free-Radical Scavenging

It is thought that the molecular basis for the protective action of phenylpropanoids in plants is their antioxidant and free radical scavenging properties. Chemically, rosmarinic acid is a powerful antioxidant that can neutralize several types of reactive oxygen species and helps stabilize cell membranes. Density functional theory (DFT) calculations have been used to determine that the PPG antioxidant mechanism proceeds through a sequential proton loss single electron transfer (SPLET).

5.2 Anti-Inflammatory Signaling

Multiple phenylpropanoids suppress key inflammatory transcription factors and signaling cascades. The anti-inflammatory effects of cinnamaldehyde in short-term treatment are displayed by interruption of the degradation of IκBα, while in long-term treatment, the anti-inflammatory effects are via the induction of Nrf2-related genes, such as heme oxygenase-1 (HO-1), known to be associated with inhibition of TNF-α-induced ICAM-1 expression. Additionally, cinnamaldehyde upregulated Nrf2 nuclear extensions, increased the activity of antioxidant response element (ARE)-luciferase, and upregulated another Nrf2-related gene, namely thioredoxin reductase-1.

Almost all of the phenylpropanoids possess antimicrobial, anti-inflammatory, and anticancer activities. These are related to the different substitution of the phenylpropane molecule.

5.3 NF-κB and MAPK Pathway Modulation

The suppression of VCAM-1 and ICAM-1 was observed at the transcriptional level and NF-κB — the main downstream signal of VCAM-1 and ICAM-1 — was also suppressed in TNF-α-treated endothelial cells by cinnamaldehyde. More broadly, hydroxycinnamic acids and phenylpropanoid glycosides modulate NF-κB, MAPK (ERK, p38), and Nrf2 pathways in multiple experimental systems.

5.4 Enzyme Inhibition

Several phenylpropanoids act as inhibitors of pro-inflammatory enzymes including cyclooxygenase (COX-1 and COX-2), lipoxygenase (LOX), and nitric oxide synthase (iNOS). In animal arthritis models, p-coumaric acid remarkably suppressed the paw edema, body weight loss, and inflammatory cytokine and chemokine levels (TNF-α, IL-1β, IL-6, and MCP-1) in serum and ankle joints; it also reduced the expression of osteoclastogenic factors (RANKL and TRAP), pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-17), and inflammatory enzymes (iNOS and COX-2).

5.5 Gut Microbiota Interaction and Metabolite Production

The parent compound rosmarinic acid is rapidly converted to conjugated forms and to simpler phenolic acids such as caffeic acid and ferulic acid, which also have biological activity. Most of the absorbed dose is eliminated through the kidneys within about a day. Because much of what circulates in the bloodstream consists of metabolites rather than intact rosmarinic acid, many researchers now consider it a "pro-compound": it delivers a network of phenolic metabolites that work together, rather than acting alone.

5.6 Phytoestrogen and Hormonal Effects

Certain phenylpropanoids, particularly anethole and some lignans, exert weak estrogenic or anti-estrogenic activity. This is distinct from the stronger phytoestrogenic activity of isoflavones but is considered relevant to the reported effects of these compounds on hormonal health parameters.

6. Scientific Evidence by Health Area

6.1 Cardiovascular Health

The most directly interpretable human evidence in this category relates to ferulic acid supplementation. A randomized, double-blind, placebo-controlled trial investigated the effects of ferulic acid supplementation on lipid profiles, oxidative stress, and inflammatory status in hyperlipidemia. Subjects with hyperlipidemia were randomly divided into two groups; the treatment group (n = 24) was given ferulic acid at 1000 mg daily, and the control group (n = 24) was provided with a placebo for six weeks. Lipid profiles, biomarkers of oxidative stress, and inflammation were assessed before and after the intervention. Ferulic acid supplementation demonstrated a statistically significant decrease in total cholesterol (8.1%; p = 0.001), LDL-C (9.3%; p < 0.001), triglyceride (12.1%; p = 0.049), and increased HDL-C (4.3%; p = 0.045) compared with the placebo. Ferulic acid also significantly decreased the oxidative stress biomarker MDA (24.5%; p < 0.001). Oxidized LDL-C was significantly decreased in the ferulic acid group (7.1%; p = 0.002). Ferulic acid supplementation also demonstrated a statistically significant reduction in the inflammatory markers hs-CRP (32.66%; p < 0.001) and TNF-α (13.06%; p < 0.001). These data indicate ferulic acid supplementation can improve lipid profiles, oxidative stress, oxidized LDL-C, and inflammation in hyperlipidemic subjects, and therefore has the potential to reduce cardiovascular disease risk factors. This study is encouraging but has a small sample size (n = 48 total) and a short duration of six weeks; larger and longer-term trials are needed to confirm these findings.

Phenolic acids and flavonoids have been reported to exert antioxidant, cardioprotective, anti-inflammatory, anti-atherosclerotic, immunoregulatory, anti-allergenic, anti-thrombolytic, antimicrobial, antitumor, anti-obesity, anticancer, and anti-diabetic properties. However, from the literature review, the use of phenolic acids as drugs is promising, yet more clinical research is required before this class of phytochemicals can be used for treatment.

6.2 Inflammation and Immune Modulation

The search for alternative drugs capable of disrupting the inflammatory process has become an important issue in scientific research. Essential oils represent an important source of such substances, since their active constituents often exhibit an array of pharmacological properties, including anti-inflammatory activity. A published review presents an overview of the anti-inflammatory action exerted by phenylpropanoids from essential oils and discusses possible mechanisms of action involved in the anti-inflammatory response, assessed through specific experimental models.

Most of the anti-inflammatory evidence for individual phenylpropanoids (cinnamaldehyde, eugenol, anethole) remains at the preclinical level — cell cultures and animal models — with NF-κB suppression and cytokine reduction as documented endpoints. Clinical trials in human populations are limited. Two inflammatory pain models — acute inflammation induced by carrageenan and persistent inflammation induced by Complete Freund's Adjuvant — showed that the oral treatment with anethole (125, 250, and 500 mg/kg) in mice suppressed paw edema and myeloperoxidase (MPO) activity. These are animal data and cannot be directly extrapolated to human dosing.

6.3 Neurological and Cognitive Health

Rosmarinic acid has attracted considerable clinical research interest, being the subject of multiple clinical trials for a broad range of biomedical/therapeutic indications, including cognitive functions, pain, and nasal polyp inflammation with dietary exposures of 500–900 mg/day. While the results of such clinical trials have been encouraging, the underlying foundations that have supported the trials were largely derived from in vitro and in vivo animal model studies, often suggesting hormetic dose–response findings.

Phenylpropanoids isolated from raspberry fruit showed neuroprotective activity against the oxidative stress induced by H₂O₂ in SH-SY5Y human neuroblastoma cells, which was manifested by selective inhibition of oxidative damage pathways — though this is cell-culture evidence, not clinical data. Verbascoside has extensive pharmacological effects, including antioxidative and antineoplastic actions, and a wide range of therapeutic effects against depression. A systematic review and meta-analysis appraised preclinical and limited clinical evidence to fully discuss the anti-depression capacity of verbascoside and its holistic characteristics. A systematic review of 32 preclinical trials published up to April 2023, combined with a comprehensive bioinformatics analysis of network pharmacology and molecular docking, was conducted to elucidate the antidepressant mechanism of action of verbascoside — meaning clinical human evidence for this application remains sparse.

Verbascoside was originally isolated from mullein and can penetrate the blood–brain barrier (BBB). Acteoside (verbascoside), a phenylethanoid glycoside widely distributed in various plants, has been shown to have potential activity against Alzheimer's disease, attracting considerable attention. Nevertheless, results in the Alzheimer's space remain preclinical as of current literature.

6.4 Antimicrobial Activity

Much interest has been attracted to natural and synthetic phenylpropanoids for medicinal use as antioxidant, UV screens, anticancer, anti-virus, anti-inflammatory, wound healing, and antibacterial agents. Volatile phenylpropanoids — especially cinnamaldehyde, eugenol, and thymol — are among the most widely studied natural antimicrobials. Evidence stems predominantly from in vitro minimum inhibitory concentration (MIC) studies against bacterial and fungal pathogens, with limited human clinical trial data. Cinnamomum osmophloeum Kaneh (Lauraceae) is a tree that grows in Taiwan whose components extracted from the leaf essential oil have been reported to exhibit many biological effects such as anti-microbial, anti-fungal, and anti-inflammatory. The translation from in vitro antimicrobial potency to clinically relevant dosing in humans has not yet been robustly established in large randomized controlled trials.

6.5 Anticancer Research

In a study of cancer chemopreventive activity, six phenylpropanoids and seven phytoquinoids isolated from three Illicium plants were tested for their inhibitory activities against Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate in Raji cells. All tested compounds showed inhibitory activity against the EBV-EA activation even at 1 × 10 mol ratio, and the inhibitory activity of their compounds was found to be more than that of beta-carotene.

In vitro and in vivo studies reveal a high bioavailability of p-coumaric acid as compared to other phenolic acids. p-CouA can exert anticancer activity by different mechanisms: modulating inflammation and oxidative stress, inducing apoptosis, halting cell cycle progression, altering cellular proliferation pathways, and enhancing sensitivity to chemotherapeutic drugs. Collectively, these properties make p-CouA a promising nutraceutical candidate for phytochemical-based strategies to reduce colorectal cancer incidence and morbidity. This conclusion is based on preclinical (in vitro and animal model) data; robust clinical trials in cancer patients have not been reported.

Among phenylpropanoid glycosides, caffeic acid-containing phenylpropanoid (or phenethyl alcohol, or phenylethanoid) glycosides were found to show activity against several kinds of cancer cells in cell culture models. Some phenylpropanoids have been able to suppress the growth and metastasis of tumor xenografts in nude mice in vivo. All anticancer evidence remains preclinical.

6.6 Metabolic and Antidiabetic Effects

Phenylpropanoids and their derivatives are known to have multifaceted effects, which include antimicrobial, antioxidant, anti-inflammatory, and antidiabetic activities. Ferulic acid and caffeic acid have demonstrated insulin-sensitizing and glucose-lowering effects in animal models of type 2 diabetes. Human clinical data specifically targeting glycemic control with isolated phenylpropanoids are limited; the evidence base is more substantial for polyphenol-rich whole-food or extract interventions (such as cinnamon supplementation for blood glucose), where cinnamaldehyde and related compounds are considered contributing but not sole agents.

6.7 Atopic Dermatitis and Skin Health

Clinical trials on treating atopic dermatitis showed a significant reduction in symptoms with long-term application of rosmarinic acid preparations without adverse side effects. Topical formulations of verbascoside have been investigated for photoprotection and anti-inflammatory action on skin. Verbascoside is a phenylpropanoid glycoside known for its antioxidant, anti-inflammatory, and photoprotective actions. The biological properties of verbascoside, also known as acteoside, comprise a wide spectrum of activities including antioxidant, anti-inflammatory, photoprotective, and chelating actions.

6.8 Allergic Rhinitis

A small number of clinical trials have evaluated perilla leaf extract (a rich source of rosmarinic acid) for seasonal allergic rhinitis. In a study in healthy humans performed to determine rosmarinic acid's absorption, metabolism, and urinary excretion, six healthy men were enrolled in the study involving single intakes of perilla extract containing 200 mg RA and placebo with a 10-day interval. Broader clinical investigations at doses of up to 500–900 mg/day rosmarinic acid have been used in trials for nasal polyposis and rhinitis, as noted in systematic assessments of the compound.

7. Body Systems and Health Areas

Phenylpropanoids and their derivatives are known to have multifaceted effects which include antimicrobial, antioxidant, anti-inflammatory, and antidiabetic activities and also exhibit renoprotective, neuroprotective, cardioprotective, and hepatoprotective effects. The following body systems have associated evidence, primarily preclinical, with some human data:

Cardiovascular system: lipid modulation, antioxidant protection of LDL, anti-platelet aggregation, and anti-atherogenic effects — human RCT data available for ferulic acid at 1000 mg/day.
Nervous system: neuroprotection against oxidative damage; potential in Alzheimer's disease and depression (preclinical and limited clinical data for rosmarinic acid and verbascoside).
Immune system: modulation of cytokine production, NF-κB inhibition, and mast cell stabilization — primarily preclinical.
Metabolic/endocrine system: antidiabetic and lipid-regulating effects — animal and limited human data.
Gastrointestinal system: antimicrobial effects against gut pathogens, prebiotic-like interactions with gut microbiota.
Integumentary system (skin): photoprotection (UV-absorption by hydroxycinnamic acids), wound healing, and anti-inflammatory topical applications.
Respiratory system: anti-allergic and anti-inflammatory effects in the upper airway (clinical trials for rosmarinic acid in allergic rhinitis).
Hepatic system: hepatoprotective effects demonstrated in animal models (e.g., verbascoside against CCl₄-induced liver toxicity).

8. Dosage Forms and Doses Reported in Studies

Owing to their antioxidant, antimicrobial, and photoprotective properties, phenylpropanoids have wide application in the food (preservation, packaging films, and edible coating), pharmaceutical, cosmetic, and other industries. In supplement contexts, phenylpropanoids are delivered through several distinct forms:

Standardized botanical extracts: Herbs such as rosemary, lemon balm, basil, and cinnamon are sold as dry extracts standardized to a percentage content of a specific phenylpropanoid (e.g., rosmarinic acid, cinnamaldehyde).
Isolated phenylpropanoid preparations: Pure or near-pure ferulic acid, rosmarinic acid, and caffeic acid are available as stand-alone supplements.
Essential oils: Volatile phenylpropanoids (eugenol, cinnamaldehyde, anethole) are obtained by steam distillation and sold as essential oils, used topically or, in some cases, as food-grade flavoring agents.
Herbal teas/infusions: Aqueous preparations extract polar phenylpropanoids including glycosides and hydroxycinnamic acids.

Specific doses reported in human or controlled studies include:

Ferulic acid: The treatment group in a randomized controlled trial was given ferulic acid at 1000 mg daily for six weeks.
Rosmarinic acid: Multiple clinical trials for cognitive functions, pain, and nasal polyp inflammation used dietary exposures of 500–900 mg/day.
Rosmarinic acid pharmacokinetics: A single-dose human pharmacokinetic study used a perilla extract containing 200 mg of rosmarinic acid.
Verbascoside/acteoside (animal pharmacokinetics): After a single oral dose of acteoside in dogs, the tmax was 30–45 min, the t½ was approximately 90 min, and the absolute bioavailability was approximately 4%.
Anethole (animal studies): Oral treatment with anethole at 125, 250, and 500 mg/kg in mice suppressed inflammatory endpoints in carrageenan and CFA models. No equivalent human clinical dose data are available.

9. Pharmacokinetics

In humans, peak blood levels of total rosmarinic acid and its metabolites generally occur within one to three hours. The parent compound is rapidly converted to conjugated forms and to simpler phenolic acids such as caffeic acid and ferulic acid, which also have biological activity. Most of the absorbed dose is eliminated through the kidneys within about a day.

Rosmarinic acid and its related metabolites — methylated RA, caffeic acid, and ferulic acid — were detected in the plasma and urine after intake of perilla extract. The proportion of RA and its related metabolites excreted in the urine was 6.3 ± 2.2% of the total dose, with approximately 75% of these components being excreted within 6 hours after intake.

Ferulic acid is absorbed more quickly by the body and stays in the bloodstream for a longer period compared with other phenolic acids.

Because of their low content in plants (less than 5% w/w), and the fact that phenylpropanoid glycosides present distinct pharmacokinetic challenges, several chemical synthetic routes to produce PPGs have been developed, but their synthesis is a time-consuming process and the achieved yields are often low. Oral bioavailability of intact PPGs tends to be low (as demonstrated for acteoside at approximately 4% in dogs), with extensive presystemic hydrolysis and first-pass metabolism; this means that the biological effects observed following ingestion are partly attributable to circulating metabolites rather than the parent compound.

10. Safety Considerations and Interactions

10.1 General Safety of Common Phenylpropanoids

Rosmarinic acid is considered a safe option for consumption with diverse biological properties. Various in vitro and in vivo studies showed RA is safe and effective against several health conditions. The most commonly reported side effects of rosmarinic acid are mild digestive upset or headache; serious reactions have been rare in published short-term trials.

p-Coumaric acid has low toxicity in mice, with an LD₅₀ of 2850 mg kg⁻¹ body weight.

10.2 Genotoxic Alkenylbenzenes: Regulatory Concerns

A subset of volatile phenylpropanoids — specifically the alkenylbenzene subgroup — carries documented safety concerns that have prompted regulatory assessment by the EMA, EFSA, and IARC.

Data show that estragole and methyleugenol, like some other phenylpropanoids with allyl-function (e.g., safrole or β-asarone), may be carcinogenic when administered as pure substances at high doses in rodents.

The EMA's Committee on Herbal Medicinal Products (HMPC) recommends that, because of the generally accepted evidence of genotoxic carcinogenicity, exposure to estragole should be kept as low as practically achievable. The Committee stated that the present exposure to estragole resulting from consumption of herbal medicinal products does not pose a significant cancer risk for humans, since the doses necessary to induce a carcinogenic effect are far from physiologically relevant human doses. In particular, rodent studies show that carcinogenic events are minimally probable in the dose range of 1–10 mg/kg body weight, which is approximately 100–1000 times the anticipated human exposure to estragole. Nevertheless, the HMPC recommended minimizing exposure to estragole for sensitive groups such as young children, pregnant women, and breastfeeding women.

The evaluation by EFSA is being conducted as a consequence of the genotoxic properties of estragole, methyl eugenol, and safrole. Isoeugenol has been classified as possibly carcinogenic to humans (Group 2B) by the International Agency for Research on Cancer (IARC).

The European Food Safety Authority (EFSA) is currently preparing a scientific opinion on the safety of fennel tea for sensitive consumer groups, such as infants, children, pregnant women, and breastfeeding mothers. EFSA considers the levels of estragole, methyl eugenol, and safrole in herbal teas, spices, or dietary supplements to be decisive when it comes to an evaluation of safety.

10.3 Basil / Estragole in Common Foods and Supplements

The primary safety concern with estragole-containing botanical preparations is its demonstrated genotoxic hepatocarcinogenicity in rodents at pharmacologically excessive doses. At ordinary culinary intake levels, risk has been assessed as negligible by EMA, but concentrated supplements or essential oils may deliver substantially higher doses than dietary food use.

10.4 Drug Interactions via CYP Enzymes

Previous studies have demonstrated that long-term exposure to certain dietary phytochemicals can alter the basal expression and function of various drug-metabolizing enzymes, such as cytochrome P-450s (CYPs), as well as drug uptake and efflux transporters (e.g., ABCB1 and ABCG2). While chronic consumption of some phytochemicals may have benefits for healthy individuals, others can pose life-threatening health risks under certain conditions, particularly in the context of long-term disease. Coumarins, in particular, can have complex interactions with CYP2A6, CYP1A2, and related enzymes; the extent to which this is clinically relevant for supplemental doses of phenylpropanoid-containing preparations requires further evaluation. Although the pharmacological activities of cinnamon oil and cinnamaldehyde are well established, there is a lack of scientific data on their bioaccessibility, metabolic clearance, and interactions with human xenobiotic receptors, which are essential for consumer safety.

10.5 Allergic Reactions

Eugenol and cinnamaldehyde are among the more common causes of contact dermatitis from cosmetics and dental materials. Eugenol is listed as a fragrance allergen in the EU Cosmetics Regulation. These reactions are primarily relevant to topical exposure at high concentrations (as in concentrated essential oils) rather than dietary ingestion.

10.6 Summary of Evidence Strength

The evidence base for phenylpropanoids is characterized by: (a) robust mechanistic data from cell and animal studies across multiple classes; (b) a small but growing body of human clinical trials for specific compounds (ferulic acid in hyperlipidemia; rosmarinic acid in allergic rhinitis and cognition); (c) predominantly preclinical support for anti-cancer, neuroprotective, and anti-infective applications; and (d) clear regulatory concern for the alkenylbenzene subclass (estragole, methyleugenol, safrole). More clinical research is required before phenolic acid-class phenylpropanoids can be used for treatment in clinical settings.

References

Health Conditions

Health conditions that Phenylpropanoids may help support.

No conditions available.

Body Systems

Body systems that Phenylpropanoids may help support.

No body systems available.